Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms... Show more
ICLR is expected to report earnings to fall 8.21% to $3.02 per share on April 29
Q1'26
Est.
$3.02
Q4'25
Missed
by $0.02
Q3'25
Beat
by $0.01
Q2'25
Beat
by $0.07
Q1'25
Beat
by $0.01
The last earnings report on April 30 showed earnings per share of $3.29, missing the estimate of $3.31. With 1.14M shares outstanding, the current market capitalization sits at 8.82B.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ICLR showed earnings on April 30, 2026. You can read more about the earnings report here.